FdaApplication
NDA 210933
Identifiers
- fda_app_no: NDA210933
Properties
| Property | Value |
|---|---|
| applicant_name | ALCON LABORATORIES INC |
| application_type | NDA |
| approval_date | 2020-10-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EYSUVIS | LOTEPREDNOL ETABONATE | 0.25% | SUSPENSION/DROPS;OPHTHALMIC |
1 product